These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 28604170

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial.
    Sharma SK, Katoch K, Sarin R, Balambal R, Kumar Jain N, Patel N, Murthy KJR, Singla N, Saha PK, Khanna A, Singh U, Kumar S, Sengupta A, Banavaliker JN, Chauhan DS, Sachan S, Wasim M, Tripathi S, Dutt N, Jain N, Joshi N, Penmesta SRR, Gaddam S, Gupta S, Khamar B, Dey B, Mitra DK, Arora SK, Bhaskar S, Rani R.
    Sci Rep; 2017 Jun 13; 7(1):3354. PubMed ID: 28611374
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Adjunctive therapy of Mycobacterium vaccae vaccine in the treatment of multidrug-resistant tuberculosis: A systematic review and meta-analysis.
    Weng H, Huang JY, Meng XY, Li S, Zhang GQ.
    Biomed Rep; 2016 May 13; 4(5):595-600. PubMed ID: 27123253
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Mycobacterium w Immunotherapy for Treating Pulmonary Tuberculosis - a Systematic Review.
    Pandie S, Engel ME, Kerbelker ZS, Mayosi BM.
    Curr Pharm Des; 2014 May 13; 20(39):6207-14. PubMed ID: 25190062
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Pattern of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria.
    Awoyemi OB, Ige OM, Onadeko BO.
    Afr J Med Med Sci; 2002 Mar 13; 31(1):25-31. PubMed ID: 12518925
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R, Nataraj G, Kanade S, Khatri V, Mehta P.
    J Assoc Physicians India; 2012 Aug 13; 60():22-6. PubMed ID: 23405517
    [Abstract] [Full Text] [Related]

  • 54. Adjunctive therapy with V-5 Immunitor (V5) for the treatment of tuberculosis patients: a meta-analysis.
    Feng M, Ding Q, Zhong C, Li J, Wang Q, Yuan Z, Dong Y.
    Pharmazie; 2016 Sep 01; 71(9):499-503. PubMed ID: 29441844
    [Abstract] [Full Text] [Related]

  • 55. Factors associated with misdiagnosis of smear-negative tuberculosis: an experience in Taiwan.
    Yang CY, Guo HR, Cheng YY, Huang RM.
    Respir Care; 2012 May 01; 57(5):753-7. PubMed ID: 22152195
    [Abstract] [Full Text] [Related]

  • 56. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J, Lee BJ, Yoon HI, Lee CT, Lee JH.
    Int J Tuberc Lung Dis; 2012 Oct 01; 16(10):1344-8. PubMed ID: 23107634
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Using simultaneous amplification and testing method for evaluating the treatment outcome of pulmonary tuberculosis.
    Yan L, Xiao H, Zhang Q.
    BMC Infect Dis; 2018 Oct 11; 18(1):512. PubMed ID: 30309331
    [Abstract] [Full Text] [Related]

  • 60. Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine.
    Stanford J, Stanford C, Dlugovitzky D, Fiorenza G, Martinel-Lamas D, Selenscig D, Bogue C.
    Immunotherapy; 2009 Nov 11; 1(6):933-47. PubMed ID: 20635912
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.